118 related articles for article (PubMed ID: 15056460)
41. Suppression of the transcriptional activity and DNA binding of nuclear factor-kappa B by a paraneoplastic cerebellar degeneration-associated antigen.
Sakai K; Kitagawa Y; Li Y; Shirakawa T; Hirose G
J Neuroimmunol; 2001 Sep; 119(1):10-5. PubMed ID: 11525795
[TBL] [Abstract][Full Text] [Related]
42. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
43. Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes.
Korenjak M; Taylor-Harding B; Binné UK; Satterlee JS; Stevaux O; Aasland R; White-Cooper H; Dyson N; Brehm A
Cell; 2004 Oct; 119(2):181-93. PubMed ID: 15479636
[TBL] [Abstract][Full Text] [Related]
44. Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143.
Myslinski E; Gérard MA; Krol A; Carbon P
Nucleic Acids Res; 2007; 35(10):3453-64. PubMed ID: 17478512
[TBL] [Abstract][Full Text] [Related]
45. Rb/E2F: a two-edged sword in the melanocytic system.
Halaban R
Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
[TBL] [Abstract][Full Text] [Related]
46. Unusual neuro-ophthalmologic findings in a patient with anti-Yo-associated cerebellar degeneration.
Cohen AB; Zupa-Fernandez A; Dalmau J; Galetta SL
J Neurol Sci; 2004 Oct; 225(1-2):153-5. PubMed ID: 15465100
[TBL] [Abstract][Full Text] [Related]
47. [Anti-Purkinje cell antibody (anti-Yo/type 1 antibody)].
Tanaka K
Nihon Rinsho; 2010 Jun; 68 Suppl 6():526-9. PubMed ID: 20942120
[No Abstract] [Full Text] [Related]
48. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
[TBL] [Abstract][Full Text] [Related]
49. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration.
Amyes E; Curnow J; Stark Z; Corlett L; Sutton I; Vincent A
J Neuroimmunol; 2001 Mar; 114(1-2):259-64. PubMed ID: 11240040
[TBL] [Abstract][Full Text] [Related]
50. B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: implications for cell survival.
Schwab R; Caccamo A; Bettuzzi S; Anderson J; Sala A
Blood Cells Mol Dis; 2007; 39(3):263-71. PubMed ID: 17588787
[TBL] [Abstract][Full Text] [Related]
51. Study of a new PPARgamma2 promoter polymorphism and haplotype analysis in a French population.
Meirhaeghe A; Tanck MW; Fajas L; Janot C; Helbecque N; Cottel D; Auwerx J; Amouyel P; Dallongeville J
Mol Genet Metab; 2005 Jun; 85(2):140-8. PubMed ID: 15896659
[TBL] [Abstract][Full Text] [Related]
52. [Paraneoplastic cerebellar degeneration].
Tanaka M; Tanaka K
Ryoikibetsu Shokogun Shirizu; 2000; (31):65-7. PubMed ID: 11269190
[No Abstract] [Full Text] [Related]
53. Paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Bataller L; Fages E; Alberola C
Neurologia; 2011 Jun; 26(5):e3-4. PubMed ID: 21353726
[No Abstract] [Full Text] [Related]
54. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S
J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687
[TBL] [Abstract][Full Text] [Related]
55. Regulation of neuronal survival and death by E2F-dependent gene repression and derepression.
Liu DX; Greene LA
Neuron; 2001 Nov; 32(3):425-38. PubMed ID: 11709154
[TBL] [Abstract][Full Text] [Related]
56. [A case of paraneoplastic cerebellar degeneration with resting tremor].
Kurokawa T; Taniwaki T; Arakawa K; Kikuchi H; Yao T; Tanaka K; Tanaka M; Yamada T; Kira J
Rinsho Shinkeigaku; 2001 Jan; 41(1):24-30. PubMed ID: 11433763
[TBL] [Abstract][Full Text] [Related]
57. No ataxia and no Purkinje cell loss in newborn young of SJL mice with anti-Yo antibody.
Tanaka M; Tanaka K; Tsuji S
Exp Neurol; 1998 Jan; 149(1):299. PubMed ID: 9454640
[No Abstract] [Full Text] [Related]
58. Expression of messenger RNA encoding a paraneoplastic cerebellar degeneration-associated antigen in the rat hippocampus.
Sakai K; Kitagawa Y; Ogasawara T; Hirose G
Neurosci Lett; 1995 Sep; 197(1):33-6. PubMed ID: 8545049
[TBL] [Abstract][Full Text] [Related]
59. Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo").
Lennon VA; Kryzer TJ
Neurology; 1998 Jul; 51(1):327-9. PubMed ID: 9674845
[No Abstract] [Full Text] [Related]
60. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites.
Nardelli E; Currò-Dossi B; Rizzuto N; Graus F
Clin Neurol Neurosurg; 1995 Feb; 97(1):89-94. PubMed ID: 7540522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
